→Appendix 1: propylthiouracil
PDF page 837
▶Rare or very rare Agranulocytosis. bone marrow disorders
. glomerulonephritis acute. hearing impairment.
leucopenia. thrombocytopenia. vomiting
▶Frequency not known Alopecia. arthralgia. arthritis.
encephalopathy. fever. gastrointestinal disorder.
haemorrhage. headache. hepatic disorders.
hypoprothrombinaemia. interstitial pneumonitis. lupus-
like syndrome. lymphadenopathy. myopathy. nausea.
nephritis. skin reactions. taste altered. vasculitis
SIDE-EFFECTS, FURTHER INFORMATION Severe hepatic
reactions have been reported, including fatal cases and
cases requiring liver transplant—discontinue if significant
liver-enzyme abnormalities develop.
PDF page 837
Propylthiouracil can be given but the
blocking-replacement regimen is not suitable.
Propylthiouracil crosses the placenta and in high doses
may cause fetal goitre and hypothyroidism—the lowest
dose that will control the hyperthyroid state should be
used (requirements in Graves’ disease tend to fall during
pregnancy).
PDF page 837
Present in breast milk but this does not
preclude breast-feeding as long as neonatal development
is closely monitored and the lowest effective dose is used.
Amount in milk probably too small to affect infant; high
doses may affect neonatal thyroid function.
Monitoring Monitor infant’s thyroid status.
Endocrine system
PDF page 837
Manufacturer advises caution (risk
of increased half life).
Dose adjustments Manufacturer advises consider dose
reduction.
PDF page 837
Dose adjustments Use three-quarters normal dose if eGFR
10–50 mL/minute/1.73 m2.
Use half normal dose if eGFR less than
10 mL/minute/1.73 m2.
PDF page 837
Monitor for hepatotoxicity.
PDF page 837